FDA Adverse Event Malfunction Summary report: N

ARTHREX DX REINFORCEMENT MATRIX

MDR report key: 12061317 · Received June 24, 2021

Report

Report Number
2530154-2021-00003
Event Type
Malfunction
Date Received
June 24, 2021
Report Date
June 24, 2021
Manufacturer
DSM BIOMEDICAL
Product Code
FTM
PMA / PMN Number
K091499
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NO
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DURING A POST-MARKET SURVEILLANCE SEARCH OF CLINICAL LITERATURE, THE MANUFACTURER FOUND A PAPER (POLACEK M. ARTHROSCOPIC SUPERIOR CAPSULAR RECONSTRUCTION WITH ACELLULAR PORCINE DERMAL XENOGRAFT FOR THE TREATMENT OF MASSIVE IRREPARABLE ROTATOR CUFF TEARS. ARTHROSC SPORTS MED REHABIL. 2019 NOV 13;1(1):E75-E84.) WHICH OUTLINES THAT PATIENT #6 EXPERIENCED A COMPLICATION POSTOPERATIVE AFTER THE IMPLANTATION OF ARTHREX DX REINFORCEMENT MATRIX AS PART OF SUPERIOR CAPSULAR RECONSTRUCTION (SCR) SURGERY. THE PATIENT EXPERIENCED AN ADVERSE REACTION DESCRIBED AS AN "ACUTE IMMUNOLOGIC REACTION" (PAIN, SWELLING, SECRETION) BUT THERE WAS NO SURGICAL SITE INFECTION. REVISIONAL SURGERY WAS PERFORMED AND THE SURGEON NOTED THAT THE DEVICE HAD DEGRADED INTO WHITE PARTICLES. THE DEVICE WAS EXPLANTED. PATIENT EXPERIENCED CLINICAL IMPROVEMENT DURING REHABILITATION AND DID NOT REQUIRE FURTHER SURGICAL INTERVENTION.

Description of Event or Problem · 1

DURING A POST-MARKET SURVEILLANCE SEARCH OF CLINICAL LITERATURE, THE MANUFACTURER FOUND A PAPER (POLACEK M. ARTHROSCOPIC SUPERIOR CAPSULAR RECONSTRUCTION WITH ACELLULAR PORCINE DERMAL XENOGRAFT FOR THE TREATMENT OF MASSIVE IRREPARABLE ROTATOR CUFF TEARS. ARTHROSC SPORTS MED REHABIL. 2019 NOV 13;1(1):E75-E84.) WHICH OUTLINES THAT PATIENT #6 EXPERIENCED A COMPLICATION POSTOPERATIVE AFTER THE IMPLANTATION OF ARTHREX DX REINFORCEMENT MATRIX AS PART OF SUPERIOR CAPSULAR RECONSTRUCTION (SCR) SURGERY. THE PATIENT EXPERIENCED AN ADVERSE REACTION DESCRIBED AS AN "ACUTE IMMUNOLOGIC REACTION" (PAIN, SWELLING, SECRETION) BUT THERE WAS NO SURGICAL SITE INFECTION. REVISIONAL SURGERY WAS PERFORMED AND THE SURGEON NOTED THAT THE DEVICE HAD DEGRADED INTO WHITE PARTICLES. THE DEVICE WAS EXPLANTED. PATIENT EXPERIENCED CLINICAL IMPROVEMENT DURING REHABILITATION AND DID NOT REQUIRE FURTHER SURGICAL INTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
957365 ARTHREX DX REINFORCEMENT MATRIX MESH, SURGICAL, PRODUCT CODE: FTM FTM DSM BIOMEDICAL

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention